ABSTRACT OBJECTIVES This study sought to determine the natural history of contemporary alcoholic cardiomyopathy (ACM), to compare it with that of idiopathic dilated cardiomyopathy (IDCM), and to identify risk factors for poor outcome.
contradictory, with some showing a better prognosis in ACM than in IDCM (10) , and others the reverse (8, 9) . Similarly, data on the beneficial effects of abstinence from alcohol are inconsistent (8) (9) (10) 13) .
The aims of present study were to define the longterm outcome of ACM in the current era, to compare it with that of idiopathic DCM, and to determine prognostic markers.
METHODS
From January 1993 to December 2011, we collected data from all consecutive ACM patients referred for evaluation to the Heart Failure and Heart Transplant Section of the Hospital Universitario Puerta de Hierro (Madrid, Spain).
The study was approved by our institution's local review board and conformed to the principles of the Helsinki declaration.
IDCM was defined according to the World Health Organization criteria (14) . Heavy alcohol consumption was defined as a selfreported history of alcohol intake of >80 g per day (8 standard drinks) over a period of at least 5 years (8) (9) (10) . Alcohol abuse must have been maintained until <3 months before the diagnosis of DCM.
Although a specific and structured program for alcohol discontinuation was not provided, complete abstinence from alcohol was recommended to all ACM patients. During follow-up, patients were classified as abstainers if they reported complete discontinuation of alcohol consumption and as nonabstainers if they reported continued 
Natural History of Alcoholic Cardiomyopathy alcohol consumption. Nonabstainers were subsequently classified as moderate drinkers if they had reduced consumption to <80 g/day of alcohol, and as heavy-persistent drinkers if they continued abusing alcohol (>80 g/day).
In order to have a reliable and contemporary control IDCM group for comparison, for each case of ACM, we selected the next 2 consecutive new patients with IDCM evaluated at our unit during the following 30 days and at the same setting (hospitalization or outpatient clinic) as the index ACM subject.
Initial assessment of all patients included physical examination, blood tests, and 12-lead electrocardiography (ECG). Additional studies including 24-h ECG monitoring, a 6-min walk test, upright exercise testing, right-heart catheterization, electrophysiological study, cardiac magnetic resonance imaging, and endomyocardial biopsy and were performed as ordered by the treating physician. Successive tests were performed as required. Coronary angiography to rule out coronary heart disease was performed in all but 3 patients. Of these 3 cases, 2 patients had normal To predict "cardiac death or heart transplantation" from baseline variables, initially a univariate screening of all parameters at enrollment was made. Cardiac events are defined as cardiovascular death or heart transplantation.
ACM ¼ alcoholic cardiomyopathy. In order to identify independent predictors of poor prognosis, all variables that differed between groups with p < 0.10 at univariate analysis and also other variables with a p value of >0.10 that were relevant to this study (age, baseline LVEF, alcoholic cause, and alcohol abstinence), were entered into a backward stepwise selection procedure with removal based on the probability of the likelihood-ratio statistic on the maximum partial likelihood estimated.
Peak oxygen uptake, 6-min test results, and right heart hemodynamic parameters were not included in the multiple logistic regression analyses because these tests were performed in <50% of patients.
Receiver operating characteristics (ROC) analysis was carried out to assess the performance of selected variables to predict "cardiac death or heart transplantation" in ACM. Area under the ROC curve was calculated for the combination of the independent predictors of "cardiac death or heart transplantation" in this setting.
Transplant-free survival hazards ratios (HRs) and the 95% confidence interval (CI) of the significant predictor factors were also quantified with a Cox proportional hazards model (CPHM). Based on the CPHM results, a scoring system was developed. The score for each factor was 1 point, and the total score for each patient represented the sum of the scores for each factor. Scores ranged from 0 to 3, and ACM patients were divided into 4 groups (0-3).
Finally, transplantation-free survival curves were calculated according to the Kaplan-Meier method, and the log-rank test was used for the comparison between the curves. The level of statistical significance was p < 0.05. All hypothesis tests were 2-sided. The entire analysis was performed using SPSS version 14.0 software (IBM, Armonk, New York).
RESULTS
A total of 282 patients with DCM (94 ACM patients and 188 with IDCM) participated in the study (Table 1) . Of the patients, 39% (37 in the ACM group and 74 in the IDCM group) were first evaluated during hospitalization, whereas 61% were first seen at our outpatient clinic (57 ACM and 114 IDCM patients). The baseline clinical, ECG and echocardiographic characteristics of patients with ACM and IDCM are shown in reported remaining abstinent, 32% continued alcohol consumption but had reduced intake to <80 g/day, and only 5% were persistent or heavy alcohol drinkers (>80 g/day). Alcohol abuse was due to distilled spirits (76%), beer (67%), and wine (43%). Values are mean AE SD or %. *19 ACM patients with major cardiac events (61%) and 20 ACM patients without major cardiac events (32%) underwent right heart catheterization. †13 ACM patients with major cardiac events (42%) and 18 ACM patients without major cardiac events (28%) underwent a 6-min walking test. ‡10 ACM patients with major cardiac events (32%) and 17 ACM patients without major cardiac events (27%) underwent an exercise test with O2 consumption.
GGT ¼ gamma-glutamyl-transferase; other abbreviations are as shown in Table 1 . Figure 1 shows the longterm cardiovascular outcome of the ACM patients.
Factors associated with the occurrence of major cardiac events (cardiovascular death or heart transplantation) in ACM patients were absence of treatment with beta-blockers, atrial fibrillation, QRS width $120 ms, a shorter distance in the 6-minute walking test and the use of digoxin ( Of note, the chance of suffering a major cardiac event on follow-up in our ACM cohort according to the 3 above-mentioned prognostic factors was 0%, 25%, 54%, and 100% for the presence of 0, 1, 2, and 3 risk factors, respectively ( Figure 2) . The AUC obtained with these 3 prognostic factors was 0.82 (95% CI: 0.73 to 0.91) ( Table 3) . Table 4) .
No differences between ACM and IDCM patients
were observed at baseline in terms of age, ejection fraction, ECG rhythm, and heart failure treatment ( Table 1) . Among ACM patients, there was a higher prevalence of men, smokers, liver disease, and chronic obstructive pulmonary disease (COPD). ACM patients exhibited worse New York Heart Association (NYHA) functional class and higher body mass index (BMI).
The transplantation-free survival curves of ACM and IDCM cohorts are shown in Figure 3 . The transplantation-free survival rates at 1, 3, 5, and 10 years were 88 AE 3%, 80 AE 4%, 75 AE 5%, and 65 AE 6% in the ACM cohort and 74 AE 3%, 61 AE 4%, 58 AE 4%, and 46 AE 5% in the IDCM group (p < 0.01 in all cases).
DISCUSSION
This study is the largest cohort of ACM patients described to date and is the first in the modern era of heart failure therapy. It shows that approximately one-third of ACM patients have poor prognosis, whereas two-thirds of them remain clinically stable, with one-half of those recovering systolic function.
Furthermore, this study shows that presently ACM has a better prognosis than IDCM and identifies several factors associated with poor outcome in ACM.
Finally, our study did not find differences in clinical outcomes between ACM patients who abstain completely from alcohol and those who reduce intake to a moderate degree.
NATURAL HISTORY OF ALCOHOLIC CARDIOMYOPATHY.
systolic dysfunction in some alcohol abusers (15) (16) (17) (18) (19) , most likely due to a genetic susceptibility (20) . Given the high incidence of alcohol intake in industrialized nations, alcohol has been proposed as the major contributor to nonischemic DCM in Western countries (8, 9, 11) . Therefore, a better understanding of the natural history of ACM is essential for caregivers and policymakers in order to design care for this group of patients.
In this study, approximately one-third of patients with ACM died or underwent heart transplantation, a third remained clinically stable without improvement in cardiac function, and a third experienced a substantial LVEF recovery. Overall, transplantation-free survival of our ACM cohort was better than that described previously, despite a more severe clinical presentation at baseline and a more prolonged disease (Online Table 1 ) (8-10,12).
The most likely explanation is the greater use of antifailure therapies such as ACE inhibitors, betablockers, and aldosterone antagonists, but it is also possible that the low proportion of persistent-heavy drinkers in our study was also relevant.
As shown in Online Table 1 , previous studies of the natural history of ACM were performed before current heart failure drugs were available (8) (9) (10) 12) . In fact, beta-blockers were used only in 0% to 9% of patients, and information about treatment with aldosterone antagonists was not provided (most likely, only a few of those patients received these drugs) (8) (9) (10) 12 ).
Moreover, due to the era of previous studies, we could assume that both ICD and CRT devices were rarely implanted. In contrast, ACM patients in our series received modern heart failure therapies (Table 1) . At the initial evaluation, 90% of ACM patients were receiving ACEI/ARBs, 60% beta-blockers and 49% aldosterone antagonists. At the latest follow-up, 84%, 76% and 57% of patients were treated with each medication, respectively.
The natural history of ACM compared with IDCM has been a highly controversial issue. While some studies have reported better prognosis in ACM compared to IDCM (10, 13, 21) , others found the opposite (8, 9) . In this study, ACM was identified as a protective factor on multivariate analysis (Table 4) , and transplantation-free survival in ACM was better than in IDCM (Figure 3) . Similar to previous studies, we found a higher proportion of men, smokers, and liver disease and a greater BMI among alcohol drinkers (8, 9) . Perhaps for these reasons, COPD was also more frequent in ACM than in IDCM. Despite these differences, IDCM and ACM cohorts were comparable. Age, atrial fibrillation prevalence, QRS duration, and LVEF and hemodynamic parameters, which are strong predictors of cardiac events in DCM, were similar in both groups ( Table 1) .
PREDICTORS OF PROGNOSIS IN ACM.
Different factors associated with a poor prognosis have been proposed in previous ACM studies; however, those studies are hampered by a small numbers of patients and by the absence of treatment with current standard heart failure therapies (Online Table 1 ). Prazak et al. (10) found that NYHA functional class III to IV, hepatojugular reflux, and use of diuretics were markers of fatal outcome, whereas Fauchier et al. (8) found that lack of abstinence and an increased LV end-systolic diameter were the only independent Kaplan-Meier transplantation-free survival rates are shown stratified by three independent risk factors: atrial fibrillation, QRS width of >120 ms, and lack of beta-blocker therapy at baseline evaluation. predictors of cardiac death and cardiac events, respectively. Other authors have also reported that transplantation-free survival and mortality were improved among ACM patients who became abstinent, but did not mention other predictors (9, 12) .
In our study, we identified atrial fibrillation, QRS width >120 ms, and lack of beta-blockers as independent predictors of cardiac death or heart transplantation. These factors are well-known prognostic factors already identified in other DCM studies and registries (22) (23) (24) (25) and, consistently, were also identified in multivariate analysis of the entire cohort. In light of our results, identification of these factors in ACM patients should lead to close follow-up and prompt referral to a transplantation center.
Unlike ACEI, beta-blockers were not proved to be beneficial in heart failure patients at the start of the study cohort and therefore were not uniformly prescribed during the initial years of our study. Although Finally, and irrespective of time period analyzed, it is noteworthy that none of the ACM patients who reached an LVEF >40% during follow-up suffered any major cardiac event (cardiac death or heart transplantation).
EFFECT OF ALCOHOL ABSTINENCE ON CLINICAL
COURSE. Complete abstinence from ethanol is advocated in all ACM patients (7, 9, 12, 21, 26) . However, the need for complete alcohol abstinence in advanced ACM is a controversial issue (27) . Although several studies have suggested that the clinical outcome of ACM could be improved if patients abstain from alcohol (8, 9, 21, 26) , other studies have
shown that complete alcohol abstinence may not be necessary to improve LVEF (13) . Moreover, some of the previous ACM studies that advocated complete abstinence included light to moderate drinkers in the abstainers group (8, 9) or reported good improvement in moderate drinkers (21) .
We have found that ACM patients who decreased their alcohol intake to moderate levels had better outcomes than IDCM patients and outcomes similar to those of ACM patients who abandoned alcohol completely ( Figure 3) . Moreover, LVEF during followup increased significantly to a similar extent as in abstainers among ACM patients who reduced their alcohol intake to moderate levels ( Figure 4) . Of note, although all patients who reduced alcohol intake to <80 g/day were classified as moderate drinkers, the vast majority of these patients reduced alcohol intake to <20 to 30 g/day (2 to 3 standard drinks). This amount of alcohol is similar to the amount described in studies which reported that low to moderate alcohol consumption is associated with lower mortality and incidence of nonischemic heart failure (2-4).
Our findings are consistent with prior echocardiographic studies (13). Nicolas et al. (13) found that after 1 year, LVEF increased in a cohort of ACM patients who reduced their alcohol intake to <60 g/day, whereas it decreased in those who maintained an alcohol intake of >80 g/day. In our study, the 5 patients who continued drinking >80 g/day exhibited a clear deterioration of their LVEF, although the difference was not statistically significant, most likely due to the small sample size.
Finally, we could not find any differences in any of the endpoints studied in relation to the type of beverage, amount or duration of self-reported alcohol abuse, perhaps due to the high amount of alcohol necessary to qualify for the study.
STUDY LIMITATIONS. Similar to previous studies of ACM, the allocation of patients to the ACM group and into abstinent or persistent drinkers subgroups was based on patients' self-reported alcohol consumption, which may lead to underestimation. Although we used analytical markers of alcohol consumption, such as average erythrocyte volume and serum gamma-glutamyl transferase levels as an aid to establish abstinence or persistence of alcohol intake in all patients, the quantity of alcohol intake depended solely on the patients' report.
In our study, the group of patients who continued their heavy drinking after medical advice to abstain is very small (5% of cases of ACM) and does not allow for statistically sound comparison with the other groups.
Conclusions regarding this group must be drawn with caution.
The definition of ACM used in this study is widely accepted and was used in several previous studies, but may lead to an underrepresentation of women with ACM. The accepted definition of ACM does not differentiate based on sex or BMI. Alcohol affects the heart through a toxic effect that depends on the quantity of alcohol that reaches the heart. As women typically have a lower BMI than men, similar alcohol concentrations in the heart may be achieved in women with lower alcohol intake.
The multiple logistic regression analyses presented in this work were based on a stepwise selection procedure from a larger set of candidate predictor variables. Hence, there is some risk of identifying a false positive predictor due to this multiplicity problem.
Finally, our study is strongly influenced by the fact that this cohort of patients was referred to a single Heart Transplant Center from a Mediterranean country.
CONCLUSIONS
This study shows that currently the prognosis for ACM is better than that for IDCM. In our ACM cohort, approximately one-third of the ACM patients died or underwent heart transplantation, whereas another third experienced substantial cardiac recovery, and the remaining third remained clinically stable despite impaired heart function. Atrial fibrillation, QRS width CI ¼ confidence interval; OR ¼ odds ratio; other abbreviations as in Table 1 .
FIGURE 4 Changes in Left Ventricular Ejection Fraction in ACM
Comparison between left ventricular ejection fraction at baseline and at last follow-up according to alcohol consumption in patients with alcoholic cardiomyopathy (ACM).
>120 ms, and absence of beta-blocker treatment were identified as independent prognostic factors associated with poor outcome. Finally, the prognosis of ACM patients who reduce alcohol consumption to moderate levels is similar to abstainers. 
